2-Oct-2026
Tenet to Report Its Third Quarter 2026 Results on October 29
Business Wire (Fri, 2-Oct 8:00 AM ET)
Raymond James Keeps Their Buy Rating on Tenet Healthcare (THC)
TipRanks (Mon, 28-Sep 9:35 AM ET)
Tenet Announces Upsizing and Pricing of Its $2.0 Billion Private Offering of Senior Notes
Business Wire (Tue, 8-Sep 5:00 PM ET)
Tenet Announces Private Offering of Senior Notes to Refinance $1.5 Billion in Outstanding Notes
Business Wire (Tue, 8-Sep 8:22 AM ET)
Tenet to Participate in the Wells Fargo Healthcare Conference
Business Wire (Wed, 2-Sep 8:00 AM ET)
Tenet Healthcare Lifts 2026 Outlook as EBITDA Jumps, Margins Strengthen Across Segments
Market Chameleon (Fri, 24-Jul 7:07 AM ET)
Tenet Reports Strong Second Quarter 2026 Results; Raises 2026 Financial Outlook
Business Wire (Thu, 23-Jul 4:05 PM ET)
Market Chameleon (Wed, 11-Feb 3:33 AM ET)
Tenet Healthcare Lifts 2025 Outlook as Adjusted Earnings and Cash Flow Show Strong Growth
Market Chameleon (Tue, 28-Oct 3:47 AM ET)
Tenet Healthcare is a Dallas-based healthcare services organization. It operates acute and specialty hospitals (50 as of December 2025) and hundreds of ambulatory surgery centers and other outpatient facilities across the US, primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.
Tenet Healthcare trades on the NYSE stock market under the symbol THC.
As of October 2, 2026, THC stock price climbed to $258.62 with 506,221 million shares trading.
THC has a beta of 0.93, meaning it tends to be less sensitive to market movements. THC has a correlation of 0.07 to the broad based SPY ETF.
THC has a market cap of $20.82 billion. This is considered a Large Cap stock.
Last quarter Tenet Healthcare reported $6 billion in Revenue and $6.12 earnings per share. This beat revenue expectation by $207 million and exceeded earnings estimates by $1.92.
In the last 3 years, THC traded as high as $283.05 and as low as $51.04.
The top ETF exchange traded funds that THC belongs to (by Net Assets): IJH, VTI, VB, VBR, VXF.
THC has outperformed the market in the last year with a return of +27.2%, while the SPY ETF gained +16.1%. In the last 3 month period, THC beat the market returning +26.9%, while SPY returned +3.6%. However, in the most recent 2 weeks THC has underperformed the stock market by returning -1.3%, while SPY returned +1.0%.
THC support price is $248.48 and resistance is $259.46 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that THC shares will trade within this expected range on the day.
